Alkermes plc

NASDAQ:ALKS

28.45 (USD) • At close September 8, 2025
Bedrijfsnaam Alkermes plc
Symbool ALKS
Munteenheid USD
Prijs 28.45
Beurswaarde 4,696,469,100
Dividendpercentage 0%
52-weken bereik 25.165 - 36.45
Industrie Biotechnology
Sector Healthcare
CEO Mr. Richard F. Pops
Website https://www.alkermes.com

An error occurred while fetching data.

Over Alkermes plc

Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; VIVITROL for the treatment of alcohol and

Vergelijkbare Aandelen

Evotec SE logo

Evotec SE

EVO

8.69 USD

Premier, Inc. logo

Premier, Inc.

PINC

27.11 USD

Lantheus Holdings, Inc. logo

Lantheus Holdings, Inc.

LNTH

53.63 USD

Medpace Holdings, Inc. logo

Medpace Holdings, Inc.

MEDP

492.09 USD

Omnicell, Inc. logo

Omnicell, Inc.

OMCL

32.33 USD

The Ensign Group, Inc. logo

The Ensign Group, Inc.

ENSG

174.12 USD

Apellis Pharmaceuticals, Inc. logo

Apellis Pharmaceuticals, Inc.

APLS

26.91 USD

Tandem Diabetes Care, Inc. logo

Tandem Diabetes Care, Inc.

TNDM

12.5 USD

ICU Medical, Inc. logo

ICU Medical, Inc.

ICUI

130.58 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)